Billett AL - Search Results

1

Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.

Ozuah NW, Marcus KJ, LaCasce AS, Billett AL. Ozuah NW, et al. Among authors: billett al. J Pediatr Hematol Oncol. 2018 Aug;40(6):e338-e342. doi: 10.1097/MPH.0000000000001076. J Pediatr Hematol Oncol. 2018. PMID: 29293187 Free PMC article. Clinical Trial.

2

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.

Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ. Marcus KJ, et al. Among authors: billett al. Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1182-5. doi: 10.1016/s0360-3016(02)04391-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12654425 Clinical Trial.

3

Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.

Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. Smith RS, et al. J Clin Oncol. 2003 May 15;21(10):2026-33. doi: 10.1200/JCO.2003.07.124. J Clin Oncol. 2003. PMID: 12743158

4

Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.

Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Marcus KJ, et al. Among authors: billett al. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):374-9. doi: 10.1016/j.ijrobp.2004.06.012. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667955

5

Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.

Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP. Metzger ML, et al. Among authors: billett al. JAMA. 2012 Jun 27;307(24):2609-16. doi: 10.1001/jama.2012.5847. JAMA. 2012. PMID: 22735430 Free PMC article. Clinical Trial.

6

Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.

Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML. Friedmann AM, et al. Pediatr Blood Cancer. 2013 Sep;60(9):1458-63. doi: 10.1002/pbc.24568. Epub 2013 May 15. Pediatr Blood Cancer. 2013. PMID: 23677874 Free PMC article. Clinical Trial.

7

Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9).

Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Kelly ME, et al. J Pediatr Hematol Oncol. 2013 Oct;35(7):509-13. doi: 10.1097/MPH.0b013e31829f3235. J Pediatr Hematol Oncol. 2013. PMID: 23887024 Free PMC article. Clinical Trial.

8

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.

Ozuah NW, Dahmoush HM, Grant FD, Lehmann LE, LaCasce AS, Billett AL, Margossian SP. Ozuah NW, et al. Among authors: billett al. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26707. Epub 2017 Jul 11. Pediatr Blood Cancer. 2018. PMID: 28696028 Clinical Trial.

9

Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.

Metzger ML, Link MP, Billett AL, Flerlage J, Lucas JT Jr, Mandrell BN, Ehrhardt MJ, Bhakta N, Yock TI, Friedmann AM, de Alarcon P, Luna-Fineman S, Larsen E, Kaste SC, Shulkin B, Lu Z, Li C, Hiniker SM, Donaldson SS, Hudson MM, Krasin MJ. Metzger ML, et al. Among authors: billett al. J Clin Oncol. 2021 Jul 10;39(20):2276-2283. doi: 10.1200/JCO.20.03286. Epub 2021 Apr 7. J Clin Oncol. 2021. PMID: 33826362 Free PMC article. Clinical Trial.

10

Autologous bone marrow transplantation for acute lymphoblastic leukemia.

Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbell NJ, Gelber RD, Murray C, Pittinger TP, Wolfe LC, Bast RC Jr, et al. Sallan SE, et al. Among authors: billett al. J Clin Oncol. 1989 Nov;7(11):1594-601. doi: 10.1200/JCO.1989.7.11.1594. J Clin Oncol. 1989. PMID: 2809677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page